1. Academic Validation
  2. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm

Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm

  • Genet Med. 2021 Jan;23(1):111-122. doi: 10.1038/s41436-020-00947-4.
Sandy Elbitar # 1 2 Marjolijn Renard # 3 Pauline Arnaud 1 4 5 Nadine Hanna 1 4 5 Marie-Paule Jacob 1 Dong-Chuan Guo 6 Ko Tsutsui 7 Marie-Sylvie Gross 1 Ketty Kessler 8 Laurent Tosolini 1 Vincenzo Dattilo 9 Sebastien Dupont 1 Jeremie Jonquet 1 Maud Langeois 5 Louise Benarroch 1 10 Melodie Aubart 1 11 Youmna Ghaleb 1 2 Yara Abou Khalil 1 2 Mathilde Varret 1 Petra El Khoury 1 2 Benoit Ho-Tin-Noé 1 Yves Alembik 12 Sébastien Gaertner 13 Bertrand Isidor 14 Laurent Gouya 5 Olivier Milleron 5 Kiyotoshi Sekiguchi 7 Dianna Milewicz 6 Julie De Backer 3 Carine Le Goff 1 Jean-Baptiste Michel 1 Guillaume Jondeau 1 5 Lynn Y Sakai 15 Catherine Boileau # 16 17 18 Marianne Abifadel # 19 20
Affiliations

Affiliations

  • 1 Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
  • 2 Laboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Pôle Technologie-Santé, Saint Joseph University of Beirut, Beirut, Lebanon.
  • 3 Center for Medical Genetics, Ghent University, Ghent, Belgium.
  • 4 Département de Génétique, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France.
  • 5 Hospitalo-Universitaire Xavier Bichat, APHP, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Paris, France.
  • 6 Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
  • 7 Institute for Protein Research, Osaka University, Suita, Osaka, Japan.
  • 8 Centre for Evolution and Cancer, Division of Molecular Pathology, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • 9 IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • 10 Inserm UMRS_974, Centre de recherche en myologie, G.H. Pitié-Salpétrière, APHP, Paris, France.
  • 11 Service de Neuropédiatrie, Hôpital Necker-Enfants-Malades, APHP, Paris, France.
  • 12 Department of Clinical Genetic, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • 13 Department of Hypertension, Vascular Diseases and Pharmacology, University of Strasbourg, Strasbourg, France.
  • 14 Service de Génétique Médicale, Hôpital Hôtel-Dieu, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • 15 Shriners Hospital for Children, Molecular & Medical Genetics and Biochemistry & Molecular Biology, Oregon Health & Science University, Portland, OR, USA.
  • 16 Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France. catherine.boileau@inserm.fr.
  • 17 Département de Génétique, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France. catherine.boileau@inserm.fr.
  • 18 Hospitalo-Universitaire Xavier Bichat, APHP, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Paris, France. catherine.boileau@inserm.fr.
  • 19 Laboratory for Vascular Translational Science, INSERM U1148, Université de Paris, Centre Hospitalo-Universitaire Xavier Bichat, APHP, Paris, France. marianne.abi-fadel@inserm.fr.
  • 20 Laboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Pôle Technologie-Santé, Saint Joseph University of Beirut, Beirut, Lebanon. marianne.abi-fadel@inserm.fr.
  • # Contributed equally.
Abstract

Purpose: Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease with often unrecognized inherited forms. We sought to identify novel pathogenic variants associated with autosomal dominant inheritance of TAAD.

Methods: We analyzed exome Sequencing data from 35 French TAAD families and performed next-generation Sequencing capture panel of genes in 1114 unrelated TAAD patients. Functional effects of pathogenic variants identified were validated in cell, tissue, and mouse models.

Results: We identified five functional variants in THSD4 of which two heterozygous variants lead to a premature termination codon. THSD4 encodes ADAMTSL6 (member of the ADAMTS/L superfamily), a microfibril-associated protein that promotes fibrillin-1 matrix assembly. The THSD4 variants studied lead to haploinsufficiency or impaired assembly of fibrillin-1 microfibrils. Thsd4+/- mice showed progressive dilation of the thoracic aorta. Histologic examination of aortic samples from a patient carrying a THSD4 variant and from Thsd4+/- mice, revealed typical medial degeneration and diffuse disruption of extracellular matrix.

Conclusion: These findings highlight the role of ADAMTSL6 in aortic physiology and TAAD pathogenesis. They will improve TAAD management and help develop new targeted therapies.

Keywords

ADAMTSL6; THSD4; diagnosis; thoracic aortic aneurysm.

Figures